Key result
The cardiometabolic index (CMI) demonstrated a robust positive correlation with myocardial infarction, including in populations taking lipid-lowering drugs (P<0.01).
Why the study?
The cardiometabolic index is a good predictive indicator of CVD risk, but its association with myocardial infarction is not clear.
Is the cardiometabolic index (CMI) associated with the risk of myocardial infarction?
Cross-Sectional
Is the cardiometabolic index (CMI) associated with the risk of myocardial infarction?
p-value: p=<0.01
The cardiometabolic index is positively correlated with myocardial infarction, supporting its potential use as a tool for assessing cardiovascular risk.
BACKGROUND: The cardiometabolic index (CMI) combines abdominal obesity and abnormal blood lipid indices, representing a good predictive indicator of risk in cardiovascular diseases (CVDs). However, the association between CMI and myocardial infarction (MI) is not clear. OBJECTIVE: The present project was designed to explore the linkage between CMI and MI. METHODS: Data from the National Health and Nutrition Examination Survey (NHANES) 2005-2018 were employed in this project, with CMI as the independent variable and MI as the dependent variable. Weighted logistic regression was applied in the association analysis between CMI and MI. Restricted cubic spline (RCS), subgroup analysis, and interaction tests were employed to elucidate the non-linear relationship and stability of CMI and MI's link. Moreover, to verify the robustness of the results, sensitivity analysis was conducted, with the MI status of subjects taking lipid-lowering drugs as the outcome variable. RESULTS: < 0.01) between CMI and MI in the population taking lipid-lowering drugs. CONCLUSION: , and those who have drinking habits. Even after considering the impact of lipid-lowering drug therapy, the positive correlation between CMI and MI remains robust, supporting CMI as a promising tool for assessing MI risk and guiding clinical prevention. Further research is required to probe into the application of CMI in different populations and its role in the prevention of CVDs.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a cross-sectional in Myocardial infarction. Cardiometabolic index (CMI) was evaluated on Myocardial infarction (p=<0.01). The cardiometabolic index (CMI) demonstrated a robust positive correlation with myocardial infarction, including in populations taking lipid-lowering drugs (P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: